Mirae Asset Global Investments Co., Ltd. Biotechnology

Mirae Asset Global Investments Co., Ltd.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
CABA Cabaletta Bio, Inc.	$62.4M	$8,000 0.0% of portfolio	1,767	Q3 2024 Added 22.62%
EXAI Exscientia PLC	$593M	$8,000 0.0% of portfolio	1,801	Q3 2024 Added 23.1%
FULC Fulcrum Therapeutics, Inc.	$227M	$8,000 0.0% of portfolio	2,257	Q3 2024 Added 21.61%
QURE Uni Qure N.V.	$647M	$8,000 0.0% of portfolio	1,761	Q3 2024 Added 21.53%
AMLX Amylyx Pharmaceuticals, Inc.	$205M	$7,000 0.0% of portfolio	2,462	Q3 2024 Added 21.28%
ATAI Atai Life Sciences N.V.	$249M	$7,000 0.0% of portfolio	6,069	Q3 2024 Added 21.43%
MGNX Macrogenics Inc	$195M	$7,000 0.0% of portfolio	2,269	Q3 2024 Added 21.34%
CRBU Caribou Biosciences, Inc.	$99.8M	$6,000 0.0% of portfolio	3,268	Q3 2024 Added 21.22%
VTYX Ventyx Biosciences, Inc.	$118M	$5,000 0.0% of portfolio	2,556	Q3 2024 Added 21.43%
CHRS Coherus Bio Sciences, Inc.	$114M	$4,000 0.0% of portfolio	4,167	Q3 2024 Added 21.66%
ALXO Alx Oncology Holdings Inc	$72.1M	$3,000 0.0% of portfolio	1,905	Q3 2024 Added 22.51%
BLUE Bluebird Bio, Inc.	$652M	$3,000 0.0% of portfolio	6,885	Q3 2024 Added 21.15%
OVID Ovid Therapeutics Inc.	$57.7M	$3,000 0.0% of portfolio	2,567	Q3 2024 Added 21.2%
RAPT Rapt Therapeutics, Inc.	$39.1M	$2,000 0.0% of portfolio	1,262	Q3 2024 Added 21.11%
RPHM Reneo Pharmaceuticals, Inc.	$41.1M	$2,000 0.0% of portfolio	1,209	Q3 2024 Added 21.14%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	3,506	Q3 2024 Added 21.19%

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.